Medical Research News

RSS

Do COVID-19 vaccinations increase the length of the menstrual cycle?

In this interview, we speak to Professor Alison Edelman about her latest research that investigated the effects COVID-19 vaccinations have on the menstrual cycle.

4 Feb 2022

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

A recent study from Spain showed that the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can change the overall structure and diversity of the nasopharyngeal microbiota in pregnant women – which persists even weeks after clinical infection. The paper is currently available on Research Square preprint* server.

3 Feb 2022

COVID-19 vaccine unlikely to have an adverse impact on exercise performance

The COVID-19 vaccine does not impair the body's physiological response to exercise, according to a new study at The University of Arizona.

3 Feb 2022

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Researchers aimed to understand the relationship between the SARS-CoV-2 receptor-binding domain and both human receptors and therapeutic targets.

3 Feb 2022

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Researchers review existing literature to quantify the transmissibility, immune evasion, reinfection, and severity of the SARS-CoV-2 Omicron variant.

3 Feb 2022

Understanding public responses to UK's COVID test, trace and isolate measures

Researchers investigate the public behaviors in response to the United Kingdom test, trace, and isolate (TTI) policy in July 2021.

3 Feb 2022

The spread of menstrual irregularity and COVID-19 vaccines concerns on the web

researchers discuss their findings from an analysis of data searches with a focus on menstrual irregularities and COVID-19 vaccine concerns.

3 Feb 2022

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

Researchers evaluate how the D614G and P681H mutations alter the attributes of SARS-CoV-2 VOCs.

3 Feb 2022

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

Researchers discuss the results of a human challenge study to provide novel insights into the early dynamics of SARS-CoV-2 infection.

3 Feb 2022

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

If the United States ignores COVID-19 in Nigeria, we forgo global genomic surveillance at our own peril, reports a new Northwestern Medicine study published in Nature Communications.

3 Feb 2022

Study reveals brain region that plays vital role in making sure people say words as intended

A region crossing the folded surface of the top of the brain, called the dorsal precentral gyrus, plays an essential role in how people use the sound of their voices to control how they want the words to sound, a new study shows.

3 Feb 2022

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Scientists at Roswell Park Comprehensive Cancer Center have identified a potential new target for the treatment of pancreatic cancer.

3 Feb 2022

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug.

3 Feb 2022

Expanded Child Tax Credit did not lead to employment declines, analysis shows

An analysis of Census Pulse Survey data from the Social Policy Institute at Washington University in St. Louis shows that the expanded Child Tax Credit (CTC) did not cause an exit from the labor force.

3 Feb 2022

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

For many COVID-19 patients with irrecoverable lung damage, transplantation is the only option for survival. However, there is limited information about the long-term outcomes of these patients, including postoperative complications, hospital length of stay and survival.

3 Feb 2022

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

A central feature of type 1 diabetes is loss of the pancreatic beta cells that make insulin. Researchers led by Paolo Fiorina, MD, PhD, of Boston Children's Hospital and Francesca D'Addio, MD, of the University of Milan now identify a harmful cellular pathway that causes these cells to die.

3 Feb 2022

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

The risk of stroke among older adults diagnosed with COVID-19 was highest within the first three days of diagnosis, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Study examines the prevalence and predictors of food insecurity among stroke survivors

One in three stroke survivors in the U.S. have food insecurity, which is nearly double the prevalence among people who have not had a stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Loneliness during teenage years increases risk of many negative outcomes

New research from the Institute of Psychiatry, Psychology, & Neuroscience at King's College London has found that young people who experience loneliness during early adolescence (age 12) are at greater risk of leaving school with lower grades than their non-lonely counterparts, even if they stop being lonely later on.

3 Feb 2022

Gene therapy may be a curative treatment option for patients with transfusion-dependent beta-thalassemia

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.

3 Feb 2022

Medical Research News

Do COVID-19 vaccinations increase the length of the menstrual cycle?

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

COVID-19 vaccine unlikely to have an adverse impact on exercise performance

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Understanding public responses to UK's COVID test, trace and isolate measures

The spread of menstrual irregularity and COVID-19 vaccines concerns on the web

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

Study reveals brain region that plays vital role in making sure people say words as intended

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

Expanded Child Tax Credit did not lead to employment declines, analysis shows

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

Study examines the prevalence and predictors of food insecurity among stroke survivors

Loneliness during teenage years increases risk of many negative outcomes

Gene therapy may be a curative treatment option for patients with transfusion-dependent beta-thalassemia

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News